131 related articles for article (PubMed ID: 21472888)
1. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer.
Chien MH; Chou LS; Chung TT; Lin CH; Chou MY; Weng MS; Yang SF; Chen MK
Head Neck; 2012 Mar; 34(3):405-11. PubMed ID: 21472888
[TBL] [Abstract][Full Text] [Related]
2. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
[TBL] [Abstract][Full Text] [Related]
3. Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.
Deng QW; He BS; Pan YQ; Sun HL; Xu YQ; Gao TY; Li R; Song GQ; Wang SK
Asian Pac J Cancer Prev; 2014; 15(8):3705-13. PubMed ID: 24870781
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population.
Lu Y; Xu YC; Shen J; Yu RB; Niu JY; Guo JT; Hu X; Shen HB
World J Gastroenterol; 2005 Jan; 11(1):56-60. PubMed ID: 15609397
[TBL] [Abstract][Full Text] [Related]
5. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
[TBL] [Abstract][Full Text] [Related]
6. CDH1 promoter polymorphism (-347G-->GA) is a possible prognostic factor in sporadic colorectal cancer.
Zou XP; Dai WJ; Cao J
World J Gastroenterol; 2009 Nov; 15(42):5340-5. PubMed ID: 19908344
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
8. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
9. CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysis.
Chu CM; Chen CJ; Chan DC; Wu HS; Liu YC; Shen CY; Chang TM; Yu JC; Harn HJ; Yu CP; Yang MH
World J Surg Oncol; 2014 Mar; 12():80. PubMed ID: 24684952
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.
Wang Y; Yang H; Li L; Wang H; Zhang C; Xia X
Int J Colorectal Dis; 2012 Feb; 27(2):151-8. PubMed ID: 21997289
[TBL] [Abstract][Full Text] [Related]
11. Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population.
Zhao L; Wang YX; Xi M; Liu SL; Zhang P; Luo LL; Liu MZ
Int J Clin Exp Pathol; 2015; 8(5):5753-60. PubMed ID: 26191293
[TBL] [Abstract][Full Text] [Related]
12. Association of CDH1 and TERT Single-Nucleotide Polymorphisms with Susceptibility to Familial Breast Cancer Risk.
Bagherpour M; Gharibzad K; Rassi H
Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):239-244. PubMed ID: 30543312
[TBL] [Abstract][Full Text] [Related]
13. Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas.
Zhang XF; Wang YM; Ge H; Cao YY; Chen ZF; Wen DG; Guo W; Wang N; Li Y; Zhang JH
Dis Esophagus; 2008; 21(1):21-9. PubMed ID: 18197935
[TBL] [Abstract][Full Text] [Related]
14. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
15. The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.
Wang Q; Gu D; Wang M; Zhang Z; Tang J; Chen J
DNA Cell Biol; 2011 Jun; 30(6):395-400. PubMed ID: 21214416
[TBL] [Abstract][Full Text] [Related]
16. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161
[TBL] [Abstract][Full Text] [Related]
17. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population.
Zhan Z; Wu J; Zhang JF; Yang YP; Tong S; Zhang CB; Li J; Yang XW; Dong W
Mol Biol Rep; 2012 Aug; 39(8):8107-13. PubMed ID: 22535324
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
19. Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
Shih LC; Li CH; Sun KT; Chen LY; Hsu CL; Hung YW; Wu CN; Hsia TC; Shen TC; Chang WS; Shih TC; Tsai CW; Bau DT
Anticancer Res; 2018 Apr; 38(4):2087-2092. PubMed ID: 29599326
[TBL] [Abstract][Full Text] [Related]
20. CDH1 promoter polymorphism and stomach cancer susceptibility.
Li YL; Tian Z; Zhang JB; Fu BY
Mol Biol Rep; 2012 Feb; 39(2):1283-6. PubMed ID: 21625863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
